Emcure Pharmaceuticals Limited (BOM:544210)
India flag India · Delayed Price · Currency is INR
1,961.80
+46.60 (2.43%)
At close: Sep 10, 2026

Emcure Pharmaceuticals Statistics

Total Valuation

BOM:544210 has a market cap or net worth of INR 375.36 billion. The enterprise value is 389.36 billion.

Market Cap375.36B
Enterprise Value 389.36B

Important Dates

The next estimated earnings date is Friday, November 6, 2026.

Earnings Date Nov 6, 2026
Ex-Dividend Date Sep 4, 2026

Share Statistics

Current Share Class 189.68M
Shares Outstanding n/a
Shares Change (YoY) +0.24%
Shares Change (QoQ) +0.05%
Owned by Insiders (%) 70.34%
Owned by Institutions (%) 12.73%
Float 41.76M

Valuation Ratios

The trailing PE ratio is 37.11 and the forward PE ratio is 29.92.

PE Ratio 37.11
Forward PE 29.92
PS Ratio 3.88
PB Ratio 7.54
P/TBV Ratio 9.75
P/FCF Ratio 64.39
P/OCF Ratio 39.78
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 20.44, with an EV/FCF ratio of 66.79.

EV / Earnings 38.50
EV / Sales 4.02
EV / EBITDA 20.44
EV / EBIT 26.53
EV / FCF 66.79

Financial Position

Current Ratio n/a
Quick Ratio n/a
Debt / Equity 0.31
Debt / EBITDA 0.80
Debt / FCF 2.61
Interest Coverage 9.89

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) n/a
Return on Invested Capital (ROIC) 16.93%
Return on Capital Employed (ROCE) n/a
Weighted Average Cost of Capital (WACC) n/a
Revenue Per Employee 14.01M
Profits Per Employee 1.46M
Employee Count6,914
Asset Turnover n/a
Inventory Turnover n/a

Taxes

In the past 12 months, BOM:544210 has paid 3.71 billion in taxes.

Income Tax 3.71B
Effective Tax Rate 26.69%

Stock Price Statistics

The stock price has increased by +44.11% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change +44.11%
50-Day Moving Average 1,892.23
200-Day Moving Average 1,646.48
Relative Strength Index (RSI) 64.58
Average Volume (20 Days) 60,109

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, BOM:544210 had revenue of INR 96.83 billion and earned 10.11 billion in profits. Earnings per share was 53.35.

Revenue96.83B
Gross Profit 57.55B
Operating Income 14.68B
Pretax Income 13.90B
Net Income 10.11B
EBITDA 19.05B
EBIT 14.68B
Earnings Per Share (EPS) 53.35
Full Income Statement

Balance Sheet

The company has 1.48 billion in cash and 15.21 billion in debt, with a net cash position of -13.74 billion.

Cash & Cash Equivalents 1.48B
Total Debt 15.21B
Net Cash -13.74B
Net Cash Per Share n/a
Equity (Book Value) 49.77B
Book Value Per Share 261.12
Working Capital n/a
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 9.44 billion and capital expenditures -3.61 billion, giving a free cash flow of 5.83 billion.

Operating Cash Flow 9.44B
Capital Expenditures -3.61B
Depreciation & Amortization 4.37B
Net Borrowing 4.88B
Free Cash Flow 5.83B
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 59.43%, with operating and profit margins of 15.16% and 10.44%.

Gross Margin 59.43%
Operating Margin 15.16%
Pretax Margin 14.35%
Profit Margin 10.44%
EBITDA Margin 19.67%
EBIT Margin 15.16%
FCF Margin 6.33%

Dividends & Yields

This stock pays an annual dividend of 3.60, which amounts to a dividend yield of 0.19%.

Dividend Per Share 3.60
Dividend Yield 0.19%
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -0.24%
Shareholder Yield -0.06%
Earnings Yield 2.69%
FCF Yield 1.55%
Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Analyst Forecast

The average price target for BOM:544210 is 2,225.63, which is 13.45% higher than the current price. The consensus rating is "Strong Buy".

Price Target 2,225.63
Price Target Difference 13.45%
Analyst Consensus Strong Buy
Analyst Count 8
Revenue Growth Forecast (3Y) 13.34%
EPS Growth Forecast (3Y) 21.17%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 3